BRCA2 and breast neoplasm: Although in a minor proportion, our data are in accordance with the results published by the CIMBA group, where the authors reported that 77.0% of women with mutations in BRCA1 had grade III breast tumors, compared to only 50.0% of women with mutations in BRCA2 (Mavaddat et al., 2012).